Home / Research Library / Targeting HER2-positive breast cancer: advances an...
🧬 Medicine & Biology OpenAlex

Targeting HER2-positive breast cancer: advances and future directions

📅 November 7, 2022 👤 Sandra M. Swain, Mythili Shastry, Erika Hamilton 📖 Nature Reviews Drug Discovery 📊 1,060 citations

🤖 Plain-English Summary

This research explores Targeting HER2-positive breast cancer: advances and future d..., contributing new insights to the field of Medicine & Biology.

🔑 Key Findings

  • Research demonstrates significant advances in patient outcome data
  • Study provides new evidence regarding clinical efficacy results
  • Findings open new directions for biological mechanism insights

💡 Why This Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

Read the full paper
Access the original peer-reviewed research via OpenAlex.

View on DOI ↗

📋 Article Details

Category 🧬 Medicine & Biology
Published Nov 07, 2022
Journal Nature Reviews Drug Discovery
Authors Sandra M. Swain, Mythili Shastry, Erika Hamilton
DOI 10.1038/s41573-022-00579-0
Citations 1,060
Source OpenAlex

More 🧬 Medicine & Biology Research